Truveris Expands Clinical Expertise with Several New Hires
Our expanded clinical team will further strengthen Truveris’ ability to provide leading pharmacy advisory support for employers and benefits consultants.| Truveris
TrumpRx signals a push towards more consumer-facing drug pricing, but the impact to plans is predicted to be low or modest until more information becomes available.| Truveris
Most-Favored Nation (MFN) pricing refers to matching the lowest available price for a drug in peer nations. Emerging MFN arrangements with pharma manufacturers could drive broader adoption.| Truveris
The Trump administration’s pharmaceutical tariffs policy is intended to encourage U.S.-based manufacturing, reduce reliance on foreign supply chains, and lower drug costs.| Truveris
Our expanded clinical team will further strengthen Truveris’ ability to provide leading pharmacy advisory support for employers and benefits consultants.| Truveris
Review the basics of PBM guarantees, where they can lose value, and find steps employers can take to keep guarantees working in their favor.| Truveris
Access our latest eBook about reducing total pharmacy costs while centering around plan transparency and aligned incentives.| Truveris
Lowest net cost offers a holistic strategy for PBM contracting and claims management that prioritizes the actual, all-in cost of the plan.| Truveris
Truveris experts break down how pharmacy guarantees work, hidden factors that can water them down, and best practices for reviewing guarantees.| Truveris
To understand how GLP-1s are impacting pharmacy benefits, Truveris has created resources to support strategies to manage GLP-1 costs.| Truveris
Contract oversight gave key visibility into unintended GLP-1 claims coverage, allowing the plans, consultant, and PBM to address the issue.| Truveris
For plans navigating GLP-1 coverage, it's important to understand their utilization as you build pharmacy spend strategies.| Truveris
Access our eBook that dives into how pharmacy coalitions are structured and ways for employers to evaluate their impact to pharmacy programs.| Truveris
